Abiopharma

NU SKIN ENTERPRISES, INC. (NUS)

Symbol	NUS
Name	NU SKIN ENTERPRISES, INC.
Sector	HEALTH CARE
Region	North America
Industry	Other Pharmaceuticals
Address	75 WEST CENTER STREET, PROVO, Utah, 84601, United States
Telephone	+1 801 345-1000
Fax	—
Email	—
Website	https://www.nuskin.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001021561
Description	Nu Skin Enterprises Inc is a health and beauty direct-selling company with a comprehensive product line: anti-aging skin products; peels, masks, and scrubs; moisturizers; body care; hair care; mens care; oral care; sun protection; and cosmetics. The company has three main product divisions: anti-aging, skin, and pharmaceuticals. The pharmaceuticals division offers nutritionals, weight-management products, and food supplements. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific. Additional info from NASDAQ: Nu Skin Enterprises Inc is a health and beauty direct-selling company with a comprehensive product line: anti-aging skin products; peels, masks, and scrubs; moisturizers; body care; hair care; mens care; oral care; sun protection; and cosmetics. The company has three main product divisions: anti-aging, skin, and pharmaceuticals. The pharmaceuticals division offers nutritionals, weight-management products, and food supplements. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.

2026-06-11 20:38

Director WOODBURY EDWINA D 🟢 acquired 19 shares of NU SKIN ENTERPRISES, INC. (NUS) at $5.43 Transaction Date: Jun 10, 2026 | Filing ID: 000063

2026-06-03 21:10

Director Winett James M 🟡 adjusted position in 19.4K shares of NU SKIN ENTERPRISES, INC. (NUS) at $5.62 Transaction Date: Jun 01, 2026 | Filing ID: 000061

2026-06-03 21:09

Director Nathanson Laura 🟢 acquired 26.6K shares of NU SKIN ENTERPRISES, INC. (NUS) Transaction Date: Jun 01, 2026 | Filing ID: 000060

2026-06-03 21:08

Director Zorko Mark A 🟢 acquired 26.6K shares of NU SKIN ENTERPRISES, INC. (NUS) Transaction Date: Jun 01, 2026 | Filing ID: 000059

2026-06-03 21:07

Director WOODBURY EDWINA D 🟡 adjusted position in 19.4K shares of NU SKIN ENTERPRISES, INC. (NUS) at $5.70 Transaction Date: Jun 01, 2026 | Filing ID: 000058

2026-06-03 21:06

Director Battle Emma S. 🟢 acquired 26.6K shares of NU SKIN ENTERPRISES, INC. (NUS) Transaction Date: Jun 01, 2026 | Filing ID: 000057

2026-06-03 21:06

Director Thomas Pisano R. 🟢 acquired 26.6K shares of NU SKIN ENTERPRISES, INC. (NUS) Transaction Date: Jun 01, 2026 | Filing ID: 000056

2026-06-03 21:05

Director CAMPBELL DANIEL W 🟢 acquired 26.6K shares of NU SKIN ENTERPRISES, INC. (NUS) Transaction Date: Jun 01, 2026 | Filing ID: 000055

2026-06-02 14:38

📋 Winett James M (Director) plans to sell 7K shares of NU SKIN ENTERPRISES, INC. (at $5.62 each, total $40K) Filed: Jun 02, 2026 | ID: 004237

2026-06-01 18:20

New Form S-8 - NU SKIN ENTERPRISES, INC. Filed: 2026-06-01 AccNo: 0001140361-26-023595 Size: 205 KB

Trial ID	Title	Phase	Indication	Status	Start Date	Completion Date	Source
NCT07198503	Study on Carotenoid-Based Instrumental Index	—	Skin Carotenoid Status	Recruiting	2025-09-06	2025-10-16	ClinicalTrials.gov
NCT07207252	Research on Sleep and Emotion Testing of Tea Theanine Casein Hydrolysate Presse…	Na	Mild to Moderate Sleep Disorder	Completed	2024-10-28	2024-12-05	ClinicalTrials.gov
NCT04725630	Healthy Food Prescription Incentive Program	Na	Diet, Healthy	Completed	2021-05-29	2025-03-07	ClinicalTrials.gov
NCT01725958	Effects of a Nutritional Supplement Combination on Body Weight Management	Phase4	Safety/Effacy	Completed	2012-09-01	2014-10-01	ClinicalTrials.gov
NCT00836342	Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer	—	Skin Cancer	Completed	2009-02-01	2012-01-01	ClinicalTrials.gov
NCT00541931	Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metab…	Na	Skin Diseases	Completed	2007-10-01	2012-01-01	ClinicalTrials.gov

Total clinical trials: 6

Product Name	Type	Development Stage	Therapeutic Area	Study Status	Trial ID
Healthy food prescription	Other	Approved	Diet, Healthy	COMPLETED	NCT04725630
Healthy food incentive	Other	Approved	Diet, Healthy	COMPLETED	NCT04725630
Nutritional supplement and protein shakes	Other	Phase PHASE4	Safety/Effacy	COMPLETED	NCT01725958
Nutritional supplement and protein shakes	Other	Phase PHASE4	Safety/Effacy	COMPLETED	NCT01725958
Dietary Supplement: LifePak Nano	Other	Approved	Skin Diseases	COMPLETED	NCT00541931
Dietary Supplement: LifePak Nano	Other	Approved	Skin Diseases	COMPLETED	NCT00541931
Pressed Candy	Other	Approved	Mild to Moderate Sleep Disorder	COMPLETED	NCT07207252
Tea Theanine Casein Hydrolysate Pressed Candy	Other	Approved	Mild to Moderate Sleep Disorder	COMPLETED	NCT07207252
Pressed Candy	Other	Approved	Mild to Moderate Sleep Disorder	COMPLETED	NCT07207252
Tea Theanine Casein Hydrolysate Pressed Candy	Other	Approved	Mild to Moderate Sleep Disorder	COMPLETED	NCT07207252
Healthy food prescription	Other	Approved	Diet, Healthy	COMPLETED	NCT04725630
Healthy food incentive	Other	Approved	Diet, Healthy	COMPLETED	NCT04725630
Healthy food prescription	Other	Approved	Diet, Healthy	COMPLETED	NCT04725630
Healthy food incentive	Other	Approved	Diet, Healthy	COMPLETED	NCT04725630

Total products: 14